awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33751191-AC5630E3-2336-4CD8-B6FF-0B1174E3714E
Q33751191-AC5630E3-2336-4CD8-B6FF-0B1174E3714E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33751191-AC5630E3-2336-4CD8-B6FF-0B1174E3714E
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.
P2860
Q33751191-AC5630E3-2336-4CD8-B6FF-0B1174E3714E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33751191-AC5630E3-2336-4CD8-B6FF-0B1174E3714E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a923f8e4fa732849066687122656f303e6c9bcc
P2860
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma.